Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study. A class of drugs for diabetes may be associated with a lower risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according to new research.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.